Statera Biopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Statera Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2022.
  • Statera Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 26, 2022 was 50.7M shares, a 58.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 50.7M +18.6M +58.1% Sep 26, 2022 10-Q 2022-10-21
Q3 2021 32.1M +18.8M +141% Nov 11, 2021 10-Q 2021-11-15
Q2 2021 15.5M +2.46M +18.9% Aug 9, 2021 10-Q 2021-08-16
Q1 2021 15.5M +4.07M +35.7% Apr 30, 2021 10-Q 2021-05-14
Q3 2020 13.3M +2.04M +18% Oct 20, 2020 10-Q 2020-11-16
Q2 2020 13M +1.72M +15.2% Jul 24, 2020 10-Q 2020-08-14
Q1 2020 11.4M +105K +0.93% Apr 22, 2020 10-Q 2020-05-15
Q3 2019 11.3M 0 0% Oct 31, 2019 10-Q 2019-11-14
Q2 2019 11.3M 0 0% Jul 31, 2019 10-Q 2019-08-14
Q1 2019 11.3M +18.4K +0.16% Mar 31, 2019 10-Q 2019-05-15
Q3 2018 11.3M +18.4K +0.16% Oct 31, 2018 10-Q 2018-11-14
Q2 2018 11.3M +18.4K +0.16% Jul 31, 2018 10-Q 2018-08-14
Q1 2018 11.3M 0 0% Feb 28, 2018 10-K 2018-03-06
Q3 2017 11.3M +293K +2.66% Nov 2, 2017 10-Q 2017-11-14
Q2 2017 11.3M +293K +2.66% Jul 31, 2017 10-Q 2017-08-14
Q1 2017 11.3M +293K +2.66% May 5, 2017 10-Q 2017-05-15
Q4 2016 11M 0 0% Feb 14, 2017 10-K 2017-02-22
Q3 2016 11M +256K +2.39% Oct 31, 2016 10-Q 2016-11-14
Q2 2016 11M +258K +2.41% Jul 29, 2016 10-Q 2016-08-15
Q1 2016 11M +6.98M +175% Apr 30, 2016 10-Q 2016-05-16
Q4 2015 11M Feb 12, 2016 10-K 2016-02-23
Q3 2015 10.7M -46.4M -81.2% Oct 30, 2015 10-Q 2015-11-09
Q2 2015 10.7M -46.4M -81.2% Jul 31, 2015 10-Q 2015-08-12
Q1 2015 4M -46.9M -92.1% May 5, 2015 10-Q 2015-05-07
Q3 2014 57.1M +12M +26.5% Nov 6, 2014 10-Q 2014-11-10
Q2 2014 57.1M +12.1M +26.9% Aug 11, 2014 10-Q 2014-08-11
Q1 2014 50.9M +6.08M +13.6% Mar 14, 2014 10-K 2014-03-17
Q4 2013 3.44M Feb 12, 2014 10-K 2015-02-27
Q3 2013 45.2M +1.75M +4.02% Nov 5, 2013 10-Q 2013-11-08
Q2 2013 45M +9.05M +25.2% Jul 31, 2013 10-Q 2013-08-09
Q1 2013 44.8M +9.22M +25.9% Mar 14, 2013 10-K 2013-03-18
Q3 2012 43.4M +7.92M +22.3% Oct 31, 2012 10-Q 2012-11-09
Q2 2012 36M +542K +1.53% Jul 31, 2012 10-Q 2012-08-09
Q1 2012 35.6M Mar 6, 2012 10-K 2012-03-13
Q3 2011 35.5M Nov 5, 2011 10-Q/A 2011-11-14
Q2 2011 35.4M Aug 5, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.